• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.16% Nasdaq Up 1.38%

    Pacira Pharmaceuticals, Inc. (PCRX)

    -NasdaqGS
    59.88 Up 2.18(3.78%) 11:58AM EST - Nasdaq Real Time Price
    Prev Close:57.70
    Open:58.46
    Bid:59.00 x 100
    Ask:59.23 x 100
    1y Target Est:89.80
    Beta:2.29015
    Earnings Date:Feb 22 - Feb 26 (Est.)
    Day's Range:57.53 - 60.38
    52wk Range:35.78 - 121.95
    Volume:214,191
    Avg Vol (3m):830,569
    Market Cap:2.20B
    P/E (ttm):229.43
    EPS (ttm):0.26
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PCRX

    Comparison

    Symbol% ChgMkt Cap
    PCRXUp 3.78%2.20B
    ALKSUp 6.43%4.64B
    DRRXUp 2.97%125.35M

    Key Statistics

    Forward P/E (1 yr):43.18
    P/S (ttm):8.78
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :1.02
    Quarterly EPS Est (Dec-15) :0.27
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):1.31

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, commercializes, and manufactures proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback